Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Company number: 0744643660 
VAT: BE0744643660 

Pharmaceutical

Life Sciences

Biotechnology

Exothera

Hanna Lesch

Vladimir Ivošev

Vincent Dubois

Bobbie Defacci

Fabien Baldacci-Cresp

Manuel Valdés

Sylvia Haller

Arnaud Lacombe

Dmitry Sorokin

Vincent Goossens

Antoine Melchior

Olivier Dezutter

Benjamin Depierreux

Process Development

Supply Chain and Quality Management

Specialists and Scientists

Business Development

Leadership Team

Project and Technical Management

��

Teams at Exothera

Process Development

Supply Chain and Quality Management

Specialists and Scientists

Business Development

Leadership Team

Project and Technical Management

��������

Teams at Exothera

Process Development

Supply Chain and Quality Management

Specialists and Scientists

Business Development

Leadership Team

Project and Technical Management

��